Not Yet Recruiting Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation NCT06911944 Conditions Abnormalities, Multiple, Alzheimer Disease, Amyloid Beta Protein, +21 more Locations Not specified View Trial Details
Completed Escitalopram Effects on CSF Amyloid Beta NCT02161458 Conditions Amyloid Beta Protein, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +1 more Locations Washington University — St Louis, Missouri, United States University of Pennsylvania — Philadelphia, Pennsylvania, United States View Trial Details
